Mostrando 7 resultados de: 7
Subtipo de publicación
Article(7)
Publisher
New England Journal of Medicine(2)
International Journal of Stroke(1)
Journal of Human Hypertension(1)
Journal of the American College of Cardiology(1)
Journal of the Neurological Sciences(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(3)
Ginecología, obstetricia, pediatría, geriatría(2)
Fisiología humana(1)
Medicina y salud(1)
Cluster-randomized, crossover trial of head positioning in acute stroke
ArticleAbstract: BACKGROUND The role of supine positioning after acute stroke in improving cerebral blood flow and thPalabras claves:Autores:Arima H., Billot L., Brunser A.M., Cui L., De Silva H.A., Forshaw D., Hackett M.L., Lavados P.M., Lee T.H., Lightbody C.E., Lim J.Y., Lin R.T., Mead G.E., Middleton S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Peng B., Robinson T.G., Rogers K., S Anderson C., Song L., Venturelli P.M., Watkins C.L., Woodward M.Fuentes:scopusBlood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study
ArticleAbstract: The Head Positioning in Acute Stroke Trial (HeadPoST) is a pragmatic, international, cluster crossovPalabras claves:Autores:Arima H., Billot L., Chalmers J., De Silva H.A., Hackett M.L., Lavados P.M., Lee T.H., Mead G.E., Middleton S., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Robinson T.G., S Anderson C., Wang X., Watkins C.L.Fuentes:scopusAlirocumab and cardiovascular outcomes after acute coronary syndrome
ArticleAbstract: BACKGROUND Patients who have had an acute coronary syndrome are at high risk for recurrent ischemicPalabras claves:Autores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Bagai A., Bahit M.C., Bhatt D.L., Bittner V.A., Brennan J.M., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Clifton S., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., Deloatch S., Devore A.D., DIaz R., Dickey S., Dilic M., Dombrowski K., Dorobantu M., Drexel H., Ducrocq G., Eapen Z., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Laucevicius A., Lecorps G., Liberopoulos E., Lopes R.D., Mahaffey K.W., Marx N., Meloni C., Morais J., Moriarty P.M., Moryusef A., Müller C.E., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Poulsen S.H., Prieto J.C., Quintero K., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Sy R.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valdovinos P.C.M., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:scopusEffects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
ArticleAbstract: Background: After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovasculPalabras claves:Autores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Baccara-Dinet M.T., Bhatt D.L., Bittner V.A., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Colhoun H.M., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., DIaz R., Dilic M., Dorobantu M., Drexel H., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Landmesser U., Laucevicius A., Lecorps G., Liberopoulos E., Loizeau V., Lopes R.D., Mahaffey K.W., Marx N., Meloni C., Montenegro Valdovinos P.C., Morais J., Moriarty P.M., Moryusef A., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Prieto J.C., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:googlescopusLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
ArticleAbstract: Background: Guidelines recommend nonstatin lipid-lowering agents in patients at very high risk for mPalabras claves:acute coronary syndrome, lipoprotein(a), low-density lipoprotein cholesterol, PCSK9 inhibitorAutores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Bagai A., Bahit M.C., Bhatt D.L., Bittner V.A., Brennan J.M., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Clifton S., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., Deloatch S., Devore A.D., DIaz R., Dickey S., Dilic M., Dombrowski K., Dorobantu M., Drexel H., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Landmesser U., Laucevicius A., Lecorps G., Liberopoulos E., Lopes R.D., Mahaffey K.W., Manvelian G., Marx N., Meloni C., Montenegro Valdovinos P.C., Morais J., Moriarty P.M., Moryusef A., Müller C.E., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Poulsen S.H., Prieto J.C., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Scemama M., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Sy R.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:googlescopusTriple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress
ArticleAbstract: Background: Patients who suffer intracerebral hemorrhage (ICH) are at very high risk of recurrent ICPalabras claves:Blood pressure lowering, Clinical trial, Hypertension, Intracerebral Hemorrhage, OutcomesAutores:Anderson C.S., Arima H., Billot L., Chalmers J., Chen C., Chow C.K., De Silva H.A., Fisher U., Freed R., Kherkheulidze T., Klijn C.J.M., Lee T.H., Lindley R.I., MacMahon S., Martins S.O., Naismith S., Octavio Marques Pontes-Neto, Robinson T.G., Rodgers A., Salman R.A.S., Schreuder F.H., Senanayake B., Song L., Thang N.H., Wahab K.W., Wang J.G., Woodward M., Zaidi W.A.W.Fuentes:scopusRegional variation in acute stroke care organisation
ArticleAbstract: Background Few studies have assessed regional variation in the organisation of stroke services, partPalabras claves:acute ischemic stroke, In- and out-hospital stroke care organisation, Intracerebral Hemorrhage, stroke, Stroke care, thrombolysisAutores:Arima H., Billot L., Cui L., De Silva H.A., Hackett M.L., Lavados P.M., Lee T.H., Lim J.Y., Lin R.T., Mead G.E., Middleton S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Peng B., Robinson T.G., S Anderson C., Song L., Venturelli P.M., Watkins C.L.Fuentes:scopus